On Oct. 19, Cerner
- Revenues beat the analyst consensus, but earnings missed by 7.6%.
- Net sales were up 17.3%, driven by the rapidly expanding health-care information technology market.
- Marginal growth in net income kept the EPS flat at $0.33.
- Revenue backlog was up 21% over last year.
(Figures in millions, except per-share data)
Income Statement Highlights
Avg. Est. |
Q3 2006 |
Q3 2005 |
Change |
|
---|---|---|---|---|
Sales |
$339 |
$345 |
$295 |
17.3% |
Net Profit |
-- |
$27 |
$27 |
0.6% |
EPS |
$0.36 |
$0.33 |
$0.33 |
0.0% |
Diluted Shares |
-- |
82 |
80 |
2.5% |
Get back to basics with a look at the income statement.
Margin Checkup
Assets |
Q3 2006 |
Q3 2005 |
Change |
---|---|---|---|
Cash + ST Invest. |
$287 |
$134 |
114.2% |
Accounts Rec. |
$352 |
$317 |
11.0% |
Inventory |
$18 |
$9 |
110.5% |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
Assets |
Q3 2006 |
Q3 2005 |
Change |
---|---|---|---|
Cash + ST Invest. |
$287 |
$134 |
114.2% |
Accounts Rec. |
$352 |
$317 |
11.0% |
Inventory |
$18 |
$9 |
110.5% |
Liabilities |
Q3 2006 |
Q3 2005 |
Change |
---|---|---|---|
Accounts Payable |
$55 |
$54 |
1.8% |
Long-Term Debt |
$190 |
$90 |
111.4% |
Learn the ways of the balance sheet.
Cash Flow Highlights
YTD 2006 |
YTD 2005 |
Change |
|
---|---|---|---|
Cash From Ops. |
$164 |
$136 |
20.8% |
Capital Expenditures |
No Data |
$49 |
N/A |
Free Cash Flow |
No Data |
$87 |
N/A |
Find out why Fools always follow the money.
Related companies:
-
McKesson
(NYSE:MCK) -
Eclipsys
(NASDAQ:ECLP) -
IMS Health
(NYSE:RX) -
Emageon
(NASDAQ:EMAG)
Related Foolishness:
Our newsletter services can help heal an ailing portfolio. Try any of them out free for 30 days.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.